Exane Derivatives’s Kaleido Biosciences, Inc. Common Stock KLDO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
2021
Q2
$157K Hold
2021
Q1
$173K Buy